WILLIAMS DOUGLAS E (President & CEO) sold 21.8% of their position (5.08K shares) of CODIAK BIOSCIENCES, INC. on the open market
Open‑market sale worth $2.9K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/23/2023ACC: 0000899243-23-002399
DirectorOfficer· President & CEO
Since Oct 2020
-5.08K
Net shares
Net seller
$2.9K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
13.67K acquired · 18.74K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+13.67K
Price / share
—
Trade value
—
% of position
142.6%
1/19/2023
9.59K→23.25K
Common Stock
Direct
Shares
−5.08K
Price / share
$0.57
Trade value
$2.92K
% of position
21.8%
1/20/2023
23.25K→18.18K
Total
Net shares
+8.59K
Net value
-$2.92K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/19/2023 | M · Option Exercise | +13.67K | — | — | 142.6% | 9.59K | 23.25K |
| Common Stock Direct | 1/20/2023 | S · Sale | −5.08K | $0.57 | $2.92K | 21.8% | 23.25K | 18.18K |
| Total | +8.59K | -$2.92K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
13.67K shares
Shares
−13.67K
Strike price
Held after
27.33K
Exercisable
—
1/19/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock13.67K shares | 1/19/2023 | M · Option Exercise | −13.67K | — | 27.33K |